CSIMarket
 
Dyne Therapeutics Inc   (DYN)
Other Ticker:  
 
 

Dyne Therapeutics Inc Income Statement Quarterly

DYN


Select the Financial Report:   Period:   Fiscal Year:

INCOME STATEMENT
(Quarterly GAAP In millions $)

(Mar 31 2015)
I. Quarter
IV. Quarter
(Dec. 31, 2014)
(Sep. 30. 2014)
III. Quarter
(June 30, 2014)
II. Quarter
(March 31. 2014)
I. Quarter
Electrical Generation Revenue 632.00 - - - -
Net sales - 599.00 615.00 521.00 762.00
Impairment And Other Charges - - - - -
Other Revenue 64.00 - - - -
Total Revenue 696.00 599.00 615.00 521.00 762.00
Cost of Revenues -441.00 357.00 387.00 365.00 552.00
Gross Profit 255.00 242.00 228.00 156.00 210.00
Selling, Administration, Marketing -30.00 151.00 139.00 165.00 136.00
Depriciation & Amortization - 62.00 61.00 57.00 67.00
Research and Development Expense - 18.00 9.00 2.00 6.00
Impairment of Long-Lived Assets Held-for-use - - - - -
Other exp. /-income - - - - -
Sale of Assets - -1.00 -3.00 -14.00 -
Utilities Operating Expense Maintenance And Operations -111.00 531.00 - - -
Reorganization Items - -399.00 - - -
Business Combination Acquisition And Integration Related Costs -90.00 192.00 - - -
Total operating costs including COS - 587.00 593.00 575.00 761.00
Operating income/-loss -40.00 12.00 22.00 -54.00 1.00
Other Deductions / - Income
Interest expense -136.00 119.00 32.00 42.00 30.00
Interest income - - - - -
Net interest expense/-income 136.00 119.00 32.00 42.00 30.00
Loss (Income) from Equity Method Investments - - - - -
Income from affiliates - - - -10.00 -
Sale of Assets - - - - -
Financing Loss/ -Income - -3.00 - - -
Other loss/ -income 5.00 -1.00 -5.00 39.00 6.00
Total costs & expenses 877.00 702.00 620.00 646.00 797.00
Income /-loss before income taxes -181.00 -103.00 -5.00 -125.00 -35.00
Income taxes expenses/-benefit - - - -3.00 2.00
Income after income taxes -181.00 -103.00 -5.00 -122.00 -37.00
Net income/-loss of other equity - - - - -
Income/-loss from cont. Ops. -181.00 -103.00 -5.00 -122.00 -37.00
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss -181.00 -103.00 -5.00 -122.00 -37.00
Noncontrolling interests -1.00 - - - -
Prefered dividends 5.00 - - - -
Other - - - - -
Income/-loss to shareholder -185.00 -103.00 -5.00 -122.00 -37.00
EBIT 0.00 16.00 27.00 -83.00 -5.00
EBITD 0.00 78.00 88.00 -26.00 62.00
EBITDA 0.00 78.00 88.00 -26.00 62.00


Per Share (GAAP Quarterly, in $) (Mar 31 2015)
I. Quarter
IV. Quarter
(Dec. 31, 2014)
(Sep. 30. 2014)
III. Quarter
(June 30, 2014)
II. Quarter
(March 31. 2014)
I. Quarter
Basic EPS (excl. extra items) -1.49 -0.86 -0.05 -1.23 -0.41
   Extraordinary items 0.00 0.02 0.00 0.00 0.00
Basic Net EPS -1.49 -0.87 -0.05 -1.23 -0.41
Basic shares outstanding (Mill. of Units) 124.00 120.00 100.00 100.00 100.00
   EPS other shares - - - - -
Diluted Net EPS -1.49 -0.87 -0.05 -1.23 -0.41
Diluted average shares (Mill. of Units) 124.00 118.00 100.00 101.00 101.00
Dividend per share - - - - -



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com